Upside Foods has announced plans to build its first large-scale cell-based meat production plant, named Rubicon, in Glenview, Illinois, US.

Animal-free dairy start-up New Culture has announced the achievement of a new milestone in the scale-up of its fermentation manufacturing.

Jellatech has announced a $3.5 million oversubscribed seed round to enable the scale-up of its cutting-edge protein manufacturing platform.

Omeat has launched Plenty, an “ethical replacement for foetal bovine serum (FBS) that is equally effective but for a fraction of the cost”.

Dyadic International has announced that its animal-free bovine serum albumin is structurally identical to commercial animal albumin.

Upside Foods bolsters executive team as it enters its next phase of growth, with new chief scientific officer and chief legal officer.

Supply Change Capital, a venture capital firm that invests in the “future of food” has announced the closing of its inaugural $40 million fu

Willow and Kalsec to advance functional ingredient development programme for a large volume savoury foods opportunity.

Bedoukian Research and Inscripta enter partnership to develop and commercialise precision fermentation products.

New assessments from Ark Biotech show how cell-based meat could quickly become competitively priced alongside traditional animal-based meat.